Accelerating Commercialization Cost Saving Health Technologies Report
-
Upload
brazil-offshore-jobs -
Category
Documents
-
view
224 -
download
0
Transcript of Accelerating Commercialization Cost Saving Health Technologies Report
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
1/25
Acclratng Cmmrcalzatn f
Cst-Savng Halth TchnlgsMAy 2012
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
2/25
ii
About the contributors
t California HealthCare Foundation wk a a
aaly flfll pm f ala f
all calfa. t Fda pp da ad
va a mpv qaly, a ffy,
ad lw f a.
Booz Allen Hamilton a a ff f
agy ad lgy lg f aly a
y. tday, fm pvd v pmaly
us gvm df, llg, ad vl
mak, ad maj pa, , ad
-f-pf gaa. b All ff l
dp fal kwldg pag agy ad
gaa, gg ad pa, lgy,
ad aalyw m w pald
xp l m ad dma aa
lp lv g plm. hal lad
ad pa b All lp m
ady f wa x.
t Robert Wood Johnson Foundation (RWJF)
f pg al ad ala
fag y. A a lag plapy
dvd xlvly mpvg al ad
ala f all Ama, Fda wk
w a dv gp f gaa ad dvdal
dfy l ad av mpv,
magfl, ad mly ag. Pj
rWJF P Pfl a f-d ad lk
yd val kg xpl l a
g dg f al ad ala.
t von Liebig Center for Entrepreneurism and
Technology Advancement a uc sa Dg Ja
sl f egg ddad alag
ala f uvy lg f
y. tg a ma f ga f pf
f p, mg, ad pal
da, v Lg c gd faly
ad vy v g lgy
mmala p.
t w ak D. hy cg, D f Gawd c f cpa iva a
uvy f calfa a bkly, ad Ja J, fd f iv, f pv pm
lla f t op iva Mdl ad nw Mdl f ealy sag capal pd f p.
t al ak Aa Apdaa, rl oa, PD, ad hal DLg f pp f
llaav ff.
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
3/25
1
contents
id 2
oppy: t hal iva impav 4
nw bd f hal tlgy 4
t rl f uvy ra 5
t callg f cmmalg ealy-sag hal tlg 6
Dffl f cmmala 6
Appa bdgg Gap 8
htAP ad Pf-f-cp sagy 11
t Wllam J. v Lg c 11
A uq Pgam 12
htAP W 15
Lkg Aad 18
nx sp f htAP W 18
ealy ig ad cda 19
ed 21
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
4/25
2
1introDuction
i Jaay 2012, The Scientist, a maga vg
a ad lgy lf , ld
a pk- lgap mp w ll p
vy a p va f 2011.1 t
dv, kw a LucAs (Ll ulawd fld cll
mg Aay plafm ad sadw magg),
wa dvlpd y a pf f lal gg
ad gg a uvy f calfa
a L Agl (ucLA) a a way pp da
dag -p ad m g.
D. Aydga oa v ld l a
$10 maal ad a pal pla
advad mpy m fld. t
dv xmplf a w wav f al lgy
a p ad a a dvlpg
wldwd. t w lg a adva fma ad mma lg
mpv ala a, a wll a ffy
ad affdaly. ulmaly, lg ld
play a l ly mpvg a g
dvlpg wld, al lpg add
m al allg f agg, y, ad
da ud sa.
Y dp m pal f v
a LucAsad gwg mpa f
v a f vav lgaadm a fa gfa dl
mmalg vy-gad v. t
a ag fm dffly aag k apal
a lak f xp dd flly dvlp
ad mak a w v. t l a may
pmg w lg v mak a
fm laay mak.
Faly, a m f pl- ad pva-
lad a wkg dg gap w
vy a ad dy g a vay
f appa, ldg mpa vg, p
va pap, va allg,
ad vy gap fdg pgam. ba
ag a ll lavly w,
akld xpm w a vay
f q, a agg a pf ag
f mmala p ad pg
val llaa w mp.
i 2011, Wllam J. v Lg c f
epm ad tlgy Advam a
uc sa Dg, pap w calfa
halca Fda, r Wd J
Fda, ad b All haml, lad agal av alld s calfa hal
tlgy Ala Pgam (htAP). t pgam
wa ad pvd a fm v
ad a calfa w
fdg ad mg mmal
lg a d ala ad xpad
a f dvd. htAP p a
q appa f addg mmala
allg, a m a gal mdl f
a lgy ala w pf f f
ppg -avg al lg a
pf f p (Poc) ag f dvlpm.
i fall 2011, htAP f am f ,
ldg D. oa a gp, v p
$100,000 a adva lg
wad mmala. A pa f a p,
awad a w gagd a ya-lg pap
w v Lg c a ld
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
5/25
3
mg ad fdg dma Poc. ba
addal dvlpm wll lkly qd f
pd a aally m mak, fll mpa
f htAP av wll maal f m
m. Wa alady la, wv, a v
a LucAs w ad a a f vvg
mmala p, ak htAP. t
mpvd dd ma a pa ad gl a
m lkly al f f lg a
a a a g-qaly a a a lw .
t p glg pp f alag
mmala f -avg al lgad xpl w htAP p a ampg
gv vav lg a a f makg
a fl a makpla.
s 2 d mpav f al
va ad d a mgg d f
lw- al lg. s 3 glg
val f allg aad w aly-ag
lgy mmala ad l m
appa f dgg gap w vy
a ad dy. s 4 a y f
htAP ad f ld pj.
t fal f p d wa
l aad f htAP awad wl ffg
da f gvm, aadm, ad
mmal akld ad g gad
fm htAP xp fa.
Photo 1. LUCAS Holographic Microscope
Credit: Holomic, LLC
Common Commercialization Terms FoundIn This Report
Technology Acceleratora pgam a
pvd fdg, v, ad pp
a ad p w
gal f alag dvlpm ad
mmala f aly-ag lg.
Proof-of-Concept (POC)a p dgd
dm mak faly f a v
y dfg al pfma aga
mak d.
Angel Capitalk apal ppld y
dvdal v, gally f
qy a-p ad aly ag mpa.
Agl vm a f ag f
$100,000$500,000.
Venture Capitalk apal ppld y a v
apal fd, a yp f fm w maag ad
v dply apal xag f qy
g-gw pva mpa. V apal
vm a f x f $2 mll.
Stages of Development
Seed/Start-Upmpay a a p
pd d dvlpm, lkly
flly paal.
Early Stagempay a a pd
v g pl pd. t
pd may mmally avalal ad
gag v.
Impact Investingmakg vm w
f ag pv al mpa yd
a faal .
Asymmetric Risk Profilea mala w
pal k ad wad f a gv vm.
Incubatora pgam gaa a
pvd p w v ad dgd ala fl
dvlpm f w mpa.
Crowdfundinga appa f ag k
apal y aag a wd f v,
a f wm mak a mall vm
llvly add apal qm.
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
6/25
Alag cmmala f c-savg hal tlg 4
2oPPortunitY:the heALth innoVAtion iMPerAtiVe
A us spm c d
aly f Affdal ca A, ad
Ama ga p f a pdal l,
aly all plal ad lad ag
g: t d f gw al pdg
aal, ad fal lw a gw p
a a k f m am.
F m a a dad, al pdg a
ly pad g dm pd
(GDP) ad wag gw.2 t c f Mda
& Mdad sv (cMs) pj a aal
al xpd wll a aly 20 p f
GDP y d f dad. Dg pd,
gvm a f pdg ld a
50 p, ad pal -f-pk may
a y a m a 40 p.3
Ladg ply v, a cmmwal
Fd ad bkg i, gg a lwg
pdg ad afmg al ym wll
q gfa va a, paym,
a dlvy, ad pa mpwm.4,5 M
al lv a fma l ad
lgy a ky f afma. cly mdal
lg ad lad ag md
av mad dv 50 p m
f pdg gw.6
hwv, al fmalg (al it), a l al
d, a dd fdaal f alg
ay fm.7 F, m g
lad av gd a w al ad mdal
lg a al play a ky l alg
afma.8
Nw Brd f Halth Tchnlgbw w xm f g- mdal
lg ad ffy-dvg al it, a w
ga f -avg al lg
mgg. t w va a appaga vg p a ala,
lf , fma lgy, ad
lmma d. (s Fg 1
fllwg pag.) A w LucAs, y a f
plafm-ad v applal mlpl
d ad w pal val ud
sa, a wll a dvlpg wld.
t a ad p dvlpg
-avg al lg a apag
w paym a a fav aly dag
ad pv, a a apalg wafl,
vlm- ad y-ad mm mdl.
iad f g-, aw- mdal lg
ad al fma ym dgd f
llg, v a lvagg lgal
advam, a ml, lw-pw
, wl wk, ad ld mpg,
afm dlvy p ad allg adal
.
if va a fl gg
v mak, -avg al lga appld lp mpv pv, dag,
ad am f da. A am m, y
wll al d f a away fm ly
a vm, y pmg m ff
f lal .
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
7/25
5
Th Rl f Unvrst RsarchDp gfa pp f dvlpm
f dpv pd ad v aldy, lag ala, lf , ad
lgy mpa ggl kp pa w
dmad f va. t allg
f dvlpg w lg may lag fm
m fm val . Fm ppv
f ladp ad v, dg w
ffg mak pfma dffl pd.
A a l, xv ad ald f y
away fm k a ld dm aal
xg v am. i add, a majy f
mply lag mpa lak a pal
md a y v paal l a
wad pfma a a k.9
cpa a ad dvlpm pa av al
dg gfa ag la 40 ya. t
adal a ad dvlpm (r&D) mdl
w mpa vd al a ad
fd fm a v yl f pfal va
ad vma adly dd, ag lag
mpa agly ly xal llaa
f dvlpg ad dffg va.
A vm a fd, v av
mgd a a agly mpa f
xal da ad fdaal lgal
advam.10 uv av a y
f a ala ad lgy ad av
pdd akg va a pawd
mlll-dlla d aa a
lgy ad i.
Y v w may mpllg xampl f val
a, gap w vy a ad
dy ma wd. W mpad w lg
ad f al pa r&D, gagg falyad a mmala f
da a faly dvlpm. A a l, a
da f apal, kwldg, ad pp f appld
a fqly pv dlay va
fm ag mak.
Dg la qa f 20 y,
vy-gad lgy f g
gg g lgy ff
f a ad va. i 1976, uvy f
calfa sa Fa (ucsF) Pf h
by ad v-apal r swa
fdd G, wld f lgy
mpay. by ad swa a mmd
$500 a a a wld am fd
mmal appla f ma DnA
lgy a by ad dvlpd w safd
g D. saly c 3 ya al.
by 1977, G pd pd f
f ma p mafad aa,
a v f dd f Ag f
blgy. o ya la, laa
a ucsF, by ld ma l g
g ma DnA lgy, ag
fda f a lmd pply f l.
t glal lgy dy a
m a $100 ll p ya . i
2009, G am a wlly wdday f sw pamaal ad
dag mpay, r, fllwg a $47
ll aq f 44 p f G
a alady wd y r a m.
G: uvy raspaw $100 bll idy 11,12
-Cost Saving
Health
Technologies
Healthc
are
IT
LifeSc
iences
Te
lecom
Low-PowerSensors
Mic
roel ectronic
s
CloudComputing
Wire
lessNe
twork
s
Figure 1. New Breed of Health Technology
Source: Booz Allen Hamilton
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
8/25
Alag cmmala f c-savg hal tlg 6
3the chALLenGe oF coMMerciALizinGeArLY-stAGe heALth technoLoGies
Dffcults f CmmrcalzatnW ampg mmal a lgy,
a fa allg dg a
f v, pp mam a may
may x a pala , ad k f fal dg aly ag
f dvlpm. Wl a a jy
q, f pl mpdma apal,
pal lma f adal lgy af,
d f pal kll, ad dffly
f avgag mplx f ala
maka mm adlk.
Lack of Risk Capital. cagg vm dyam
v la dad av ad a al gap
a apal w ga f a a
ad v apal. A d f pm,
gvm fdg ma lagly fd a,
appld a. o d, l agl ad
v apal avalal a v av
agly ald apal wad la-ag
mpa alady pd f mmal gw.
Daa fm Pwacp ad naal
V capal Aa w a al v
apal allad mpa fm d/a-p
la ag fll damaally w 1999 ad 2011,
fm $22.4 ll $6.6 ll, w al d/a-p vm dag y a fa f alm
10.13 Wl am vd 1999 laly fl
a pd f flad vm vlm ad xpa
aad w g f d m l,
f lav a f v apal y ag
ya a l valg. bw
1999 ad 2011, val f d/a-p vm
dad fm 5.5 p j 2 p f al
fdg, wl vm aly-ag mpa
gw fm 23 p aly 35 p f
al. (s Fg 2 fllwg pag.) t ag
lav a f apal a al ag f
vm dma a la mga wad l
k ad pv mpa, pv f aggga
am vd a gv ya.14
ra y c f V ra (cVr)
a uvy f nw hamp a w a
agl vg al a dad ad fd wad
lw k aa v la dad. cVr daa val
a al agl vm a dad y a d,
fm m a $30 ll 2001 appxmaly
$20 ll 2010. Alg agl v favd
aly-ag vm 2002 (47 p f alvm), d/a-p ag vm dld
j 31 p f agl apal 2010.15,16
Wl may a w agl ad d-ag
v fd appld a ad Poc pj,
d v ad agl apal gg a fw
ad fw a wllg gaml a ag.
F, a f al lgy va
pdad avg dama d,
may mply al xp lvl f
ypally qd f g-k, aly-ag vm.
Health technology innovations predicated on
achieving dramatic cost reductions may not be able to
provide the level of return that is typically expected in
exchange for high-risk, early-stage investments.
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
9/25
7
Potential Limitations of Traditional Technology Transfer.
i 1980, paag f bay-Dl A ald
v a wp f llal ppy
dvlpd d fdally fdd a ad
pakd f vy lgy af
ff (tto). Adg Aa f
uvy tlgy Maag, bay-Dl a fld
gfa gw mmala f vyv, ldg fma f m a 5,000
w mpa.17
ov m, wv, tto av ggld
ma pa f vy-ad va,
ad lma f adal lgy
af ym av m a pal a
mmala. i p
dfdg ad mm ag l f
adal lgy af, may v a
wkg mak lgy af p
fa ad m fdly. A gwg m
f a al pag p a
a tto w pgam dly fd ad
a mpa fdd vy a.
Mindset of Academic Researchers. i a w
fdg ad lgy af lma a
vm, aly-ag mmala ll q
addal kwldg ad kll a vy
a fqly d p. Aadm
av ally pad a vm w
pf a ky mva. iad, pla,
p g, ad da f d av
ppal wad f ff. hwv,
agly d vy lgy af
p, a wll a a d mv a
yd laay f pl ad pal
f, av ld may a p pa
ad llal ppy g f
mmala.
ev , a f fa malgm
w aadm ad v
(.g., pla, ), ad xp
ay ffly mv p wad
mmala. cvg a a pd
p ypally q a mak-ady lgy,a val mdl, pf f mak d, ad
-d maagm kll. Adg
rl oa, PD, xv d f v Lg
c, M aadm a av
mg p, ad fw a flly
mmal v w gda,
llaa, ad a ym f pp.
Complexity of the Healthcare Market. hala a
mplx ad gly glad dy a j
a pawk f fdal, a, ad lal law ad
gla. A gly fagmd dlvy ym
ad d paym mam a f ld
a a pa al ad al, makg
dffl aa vm apal. byd fdg,
a m al apa ldad
fl mak w g lvl f pay ad
pvd a, a wll a k-adv
glay ag ad mp fm
d mp pal .
Addg mplxy f mak
aal a f mdl ala dy. Wl f-f-v
mm ma dma fm f
paym, a wav f dmda ad k-fg
mgag paym agly wad m-
ad mdl ad aaly f al . t
ag p pp f al lgy
va, a al a mvg ag. t day f
1999 2005 2011
Seed/Start-Up
Early
5.5%2.7% 2.0%
23.1%
16.8%
34.5%
Figure 2. Change in Investment Stage as Share of TotalVenture Capital
Source: Booz Allen Hamilton analysis of data from PricewaterhouseCoopers
and the National Venture Capital Association
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
10/25
Alag cmmala f c-savg hal tlg 8
ldg y mdl ad a cPt d a
md, ad tma Ll, a v pd a
b All haml. ra ad p
dvlpg w al lg wll agly
d dma m ad val a
vm f k-ad paym.
Apprachs t Brdgng th Gapsakld a ampg dg gap
w vy a ad dy g
a vay f appa, ldg mpa vg,
p va pap, va allg,
ad vy gap fdg pgam. ea f
ff pal val vy a, ad all
may v a l f alag mmala
f -avg al lg.
Impact Investing. impa vm gally
a d- qy-ad vm mad y
fda a a dgd av a yp
al f al mpa a y ld av
g gamakg al.18 impa vg
al fda dply addal apal
ad gly pf pgamma ad vm
gal, w dpg m ad
agy f gaa. Fda may v
dly mpa ga xp dly
g alav vl, a mmm
fd fd pfl a v m-algd
ad pp.19
impa v aly ap alav
l dmadg m a a q
ppy pp mmala f aly-
ag al lg. Gv ff m
pgam algm, fda a vlk
aymm k pfl ad ap lgy val
pp a g d avg a
avdg a m ly pd dwamad
d al f ala. tadal
v ally f g- ad g-
advam pp lag vm w
pal f gfa pf, ad Maga Law,
MPP, d f calfa halca Fda
iva f udvd pgam.
Fda a play a mpa l alg
lw-, g-qaly a y fdg -avg
al lg.
Open Innovation Partnerships. t m p
va gad a aly a dad ag
w hy cg w a a w mdl f
va w mpa mmal
al ad xal va wl dg
alav paway f w da yd . i vlvg paadgm f p
va, adal r&D ml afmd
a m lly pld a fd
fdg, ga, ad mmala
f va. t m flxl mdl al
mpa mak ag d a w y
gag w xal pa ad wa l play
p f va.20 (s Fg 3.)
Without financial support for low-cost health
care innovation, the research we do at the Institute
and the work other agencies, institutions, and
entrepreneurs are undertaking will have a tougher
path toward becoming a reality and actually
lowering health care costs for the public. Gary West, chairman and founder of
West Wireless Health Institute
RESEAR H DE EL PMENT
Boundary
of the Firm
Research
Projects
Current
Market
Open Innovation Model
New
Market
Funding Generating Commercializing
Op n Innovation Mod l
Figure 3. Open Innovation Model
Henry Chesbrough, Open Innovation: The New Imperative for Creating and
Profiting from Technology, 2003
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
11/25
9
t p va paadgm p a g
val pp f al dy ad
pvd la f f aly-ag lgy
mmala. i ya, gaa
a Pf, GlaxsmKl, ad el Llly av
d p va pap a a way
lvag apal, fa, xp, ad
d apal ala mmala
f w ap.21 A a wad m-
dv paym mdl ad pald md
ala, ga llaa wll qd
amg pamaal, mdal dv, ad lgy
fm aa a mpa dag
dag d l mdfy f a
ap agad ga f gm ad
l al d daa.
Innovation Prizes and Challenges. i 2009, MKy
pd a f awad ad p aad damaally v pa dad.22
Awad av vlvd fm a l pmaly d f
gg avm a ym dgd
pd va aa a pa,
vm, ad ad gg. ov
pa 5 ya, al val f allg-ad
va fdg a ad gfaly, w
lag p pg al mad val f
mak f p ad allg w $1 ll
ad $2 ll.23
W gwg mak, ala a aad
a agly lag ad dv pl f allg-
ad va p. cpa- ad fda-
pd allg ala ly ag
fm mall p f vav al it appla
Ge $100 mll allg fd
alag d ad pald am
f a a.24
t fdal gvm al a mmd
gfa fdg wad p ad allg
g av a Mdal ivaP A f 2007, w ald a pl f $80
ll f dvlpm f vl ap. M
ff ld gy ad al va
allg, a wll a alm f a l
lag f gvm p.25, 26
t allg-ad appa ff mplmay
val f mlpl akld, ldg a,
mpa, fda, ad gvm. P
l allg a k va
lv a pf, wll-dfd plma
paway f a ffly g
pd mak, wl a am m
gfaly dg k f vm f
mpa fdg gaa. o yp f
allg, w gal a mak mla
mmy ldg, a dly pp aly-
ag dvlpm ad ala mmala
y lpg df mak famwk pd
paway ad y ag ym f pp ad
apal ad a.
University Gap Funding Programs. A gap fd
gally dfd a m maagd
ally xally a dg fdg gap w fdal fdg f
a ad f my fm d v.27
uv pag gaa av
dvlpd gap fdg pgam agm
adal lgy af p ad
a ad ala mmala.
Pgam vay wdly , , appa,
ad mmala p, a
gally gmd f pmay fd yp:
(1) alaal a, (2) Poc, (3)
fma, ad (4) gw. Fdg ypally
dd fm f ga vm a
ag fm a ll a $20,000 p $1 mll. 28
A 2011 vy f gap fd vald a m f
f, ldg g a f mmala,
mpvd g aly-ag apal,
ad gaaal . 29 (s Fg 4
fllwg pag.) i may a, a al ap
f gap fd val pp lva
f a ym a pp a ad
p y lpg m add pfgal ad qm a a ag
mmala p.
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
12/25
Alag cmmala f c-savg hal tlg 10
Government
Funded
University
Research
Advanced
Research
Projects
Agency
SBIR, STTR andInnovation Funds
Venture and Angel CapitalIncubators and
Crowdfunding
University Gap Funding
R&D Grant Funds $10Ks $100Ks $Millions
Private
Public
Universities
Basic
Research
Translational
Research
Proof of
Concept
Business
Formation
Expand and
ScaleIPO/M&A
SBIR = Small Business Innovation Research; STTR = Small Business Technology Transfer
Figure 4. Gap Funding Within the Landscape of Early-Stage Funding
Source: Adapted from Jacob Johnson, Mind the Gap: The University Gap Funding Report," innovosource, LLC, 2012
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
13/25
11
4htAP AnDthe ProoF-oF-concePt strAteGY
htAP a xampl f a gap fdg pgam a
lvag mpa vm fm fd f
av. i wa ad y Wllam J. v
Lg c f epm ad tlgy
Advam a uc sa Dg, pap
w calfa halca Fda, r
Wd J Fda, ad b All haml.
htAP a mpv pgam ala
mmala f vy a al
lg w pal f dg ala
ad xpadg a f dvd.
i f Poc ag f dvlpm, wl
g a gal lgy ala mdl
dfy vl, -avg al lg.
Th Wllam J. vn Lbg Cntrt v Lg c ff pgam ad v faly, a, ad d d
mmala f v lg fm
a. A f agy
mmala ml kw a Poc.
t Poc p dgd dm
mak faly f a v y dfg al
pfma aga mak d, dlvg
g-qaly adda w dd f mmal
. A Poc ag, a ma f d
fdg f pyp dvlpm ad a d
mmala pla gfaly a
val f lgy, makg m aav
v ad p.
i 2010, u.s. Amy tlmd ad Advad
tlgy ra c (tAtrc) ad Qalmm
i. pvdd v Lg c w ga fdg
adap Poc p a pa f a gal wl
al lgy ala pgam. t av
g dfy ad ala mmala
f vy ad a lg wl al a ld add mdal d f
mlay pl ad faml.
Wllam J. v Lg c f epm ad tlgyAdvam a uvy f calfa sa Dg
t v Lg c wa fdd 2001 ala mmala f uc sa Dgva makpla, f ad fala xag f da w uvy ad
dy, ad ppa d f pal wkpla. s p, a
vlvd w m a 300 pj, advd m a 200 faly mm ad gada d,
awadd $4.6 mll p-d ga 82 pj, ad ppd a ad gw f 32 a-p
mpa. cllvly, mpa av ad m a 200 j ad av vd m a
$100 mll fllw-p pva apal da.
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
14/25
12
A Unqu Prgramug wl al lgy ala
av a a mdl, v Lg ad htAP p
a a q pgam a wld
maa a gal f, y ad ladap
f pal appla y mvg xpl
qm a al lg wl. i
add, htAP amd dffa lf fm
lgy ala y qalfyg appla
ad aly d , a alyg ly v pf pal.
i htAP p, appla w f qd
m a am f (soi), ldg a
vvw f lgy ad ppd appla.
soi gdd m f a al pal f
dpd xp jdg ad falad al
g f appla ad lgly, ag f
dvlpm, ad pgam f. Fllwg a day
g ad lv va m a fll
ppal, a fal d f 12 papa wa vd mp f f f awad f p $100,000,
alg w a ya f mg fm a v
Lg adv.
Application Results. A f pgam, v
Lg dad a w v
ad a s calfa
g pal appla. htAP vd
64 soi p fm 11 a
g. soi fm uc sa Dg, uvy
f calfa a iv (uc iv), ucLA, ad
uvy f s calfa (usc) pd
alm 90 p f pd. t
mag 10 p gad fm pal,
a , ad a fda. A majy
f m w ld y m faly
mm fm l f gg
md, w appxmaly f appla
mg fm mldplay am pg
dpl.
Appla ppd pj a fv ag
f al lgy pag a ag f lgyk. t ldd ca Dlvy effy ad
om, baval iv, Dag
ad Mg Dv, sgal ad tap
Dv, ad tap Ag. t lag a
f appla (36 p) ppd pj f
Dag ad Mg Dv, wl tap
Ag w ppd ly 4 p f soi.
Appxmaly -d f all appla lvd
Goals of HTAP
Identify early-stage, university-based
technologies with the potential to:
Directlyorindirectlyreducethecostof
ala dlvy;
Drivethedeliveryofaservicetoalower-costg;
Useskilledprofessionalstimemoreefficiently
( al l-ad dvdal)
Apply cost-saving health technologies for:
Chronicdiseasemanagementathome;
Telehealthservices;and
Diagnostictestsandprocedures
Diagnostic andMonitoring Devices
Surgical andTherapeutic Devices
Care Deliveryfciency and Outcomes
BehavioralInterventions
TherapeuticAgents
23
18
15
6
2
Figure 5. Number of SOIs by Technology Category
Source: von Liebig Center Analysis
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
15/25
Alag cmmala f c-savg hal tlg 13
lgy wld dly lw f dlvg
ala, wl w-d ggd
pd wld mpv pa a, mpv
qaly f a f a pala g, .30
M a 20 soi ppd dag ad
mg lg, w may aly
da d w am m ffvad l xpv. Dv f m mg
a al d y falag daa
ll ad pg pvd pal wag
f m pd f ll. bf a
ld a da fqy f pala ad
dd a f adm.
oly x soi ppd lg f aval
v. t m f m wa aly
lw gv gwg lvl f a pv
ad wll amg al pla, mply,
ad pvd w d a ala
. oy ad lfyl-lad k fa
gfaly a dd f dvlpg ly
d a da, yp,
ad a da. tf, agg m
av al pvg f
d mpvg gg maagm f
da d .
i la wy fw appla agd
aval v. o a may a
f wll w al dyad mgg f av ag a
lavly dvlpm. ra may
al am a p w a fd
av ag wll lvag xg lg,
a a lk f pp mmal
w dv. Wav a, pj
a Ml Madm ( p)a ml
l f a-m wg mala ppd y
D. Mal L a uvy f calfa a iv
dma pal pw f -avg al
lg a f agg av.
Screening Process. All soi w ally d
adg a lgly qm,
pv pgam gal, ad w
pj wa yd Poc ag. (s Fg 6
fllwg pag.) t 28 soi a pad al
g w valad y a xpadd pal f
vw ad a mpa f lav mdal
mpa ad lgal vly.
t 12 fal w a pad w a v Lg
adv ppa f -p pa a
pal f dpd xp jdg a v Lgfal sa Dg. Jdg d a wgd
g ym ad f akg l f
av w, ldg D. oa, v p
$100,000 adva lg wad
mmala. t awad w jd
a pd f d dlg add ay p
q fm jdg ad vfy pa flg
a. t w wkd w v Lg
adv a a lgy dvlpm pla,
dg, ad ga paym ml. t ad
ya-lg mg pgam.
Photo 2: Mobile Mandometer
Credit: Jenny Nolstam, The Mando Group
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
16/25
14
Initial Screen
of All SOIs
Secondary
Review of SOIs
In-Person
Presentations
Winners
Selected
12-Month
Program Begins
64 28 12 4
SOIs screened for:
Eligibility
Fit with
impact/interest
areas
Stage of
development
Expanded panel
reviews SOIs for:
Relative medical
importance
Technological
novelty
Finalists present to
a panel of expert
judges
Due diligence on
tentative winners:
Open questions
Patent ling
status
Awardees work with
a von Liebig Center
advisor to develop their
plan, budget, and
payment milestones
Screening &
Selection
Researchers begin
by submitting a
statement of interest(SOI), including an
overview of their
technology and
proposed application
vLC64 28 12 vLC
Screenin &
R s r hers begin
by submit ing a
st t m nt interest(SOI), in uding n
verview of their
t hnology n
pr p s applic ti n
Figure 6. HTAP Screening and Selection Process
Source: Booz Allen Hamilton and von Liebig Center
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
17/25
htAP Winners
Awad w mad f am f fm uc iv, uc sa Dg, ad ucLA, pg w
aly-ag mpa ad w am w p-pa ag a. t wg pj d
f w p-f-a dag l, a ld-ad pa am plag ym, ad a map-
ad wg-l maagm l. b dag l w plafm-ad va w applaf mlpl da, wl am plag ad aval v lg agd a
ad y, pvly. All w pad a la w f ky al f -avg al
lgml, lw-pw , wl wk, ad ld mpg.
Microscopy on a Cell-phone as a Diagnostic Tool (LUCAS)Aydogan Ozcan, PhD, University of California, Los Angeles
STAGe
CATeGoRy
CoNDiTioN
Company Formed
Diagnostic and Monitoring Devices
Multiple
iMPACT
eNABLeRS
Cost, Quality, Access
Microelectronics, Sensors, Wireless
t ucLA gp pd a l-f, -p magg mdaly md LucAs, w al val
ll-p vd mp ad dag l, pvdg a mpa l va
al md d. t f appla f LucAs cmpl bld c (cbc).
Mdy ad maly a dppally g ld fm -p g ad dfad
ppla, palaly lvg al y aa f ud sa. Pvy, p a
ala, p , ad lw lvl f paal da a pdpg fa. o maj plm
affg yg ld dfad ppla vlaly f fllwd y ama ad
p . A al laay f ad dag ad maagm f d a cbc,
f m wdly dd laay md.
W a avalaly f cbc l, pya, pya aa, pa wll
a p mak a dag ad p g dg dg a al pa a a
a ak pla paally ayw, w l la a v (a mpla
p mm). t plafm a al d, g lmd, gd fal mdal
v. F, y dg - a a dg ld pm d laa,
pvd a ap gfa addal val f mlv . t f pala
mpa f may gaa a a ally dfdd ad dpd gvm
plap ag.
Alag cmmala f c-savg hal tlg 15
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
18/25
Low-Cost Semiconductor Test Strips for Accurate In Vitro DiagnosticsChi On Chui, PhD, University of California, Los Angeles
STAGe
CATeGoRy
CoNDiTioN
Pre-incorporation
Diagnostic and Monitoring Devices
Multiple
iMPACT
eNABLeRS
Cost, Access
Microelectronics, Sensors
t pj k xpl a lw-, a-gd lgy f apd, p-f a dag
(.g., emgy Dpam, iv ca u, amla, pya ff, .). Poc daa a
ad ad dma 10 m ga vy, w l avalal m. t f
dag ag f lgy a ada jy mak a appa aly ld ampl,
a vy lw a mmdaly fllwg a aak. t plafm lgy wll pakagd
a mpl adld ad fad w a dpal p ad wll lmaly appld
da dag p-f-a a w a f , fa l, ad lw a al f
adp, pally aa w ala a adqa.
GPU and Cloud-Based Next-Generation Cancer RadiotherapyTreatment PlanningSteve Jiang, PhD, and Yuanyuan Zhou, PhD, University of California, San Diego
STAGe
CATeGoRy
CoNDiTioN
Pre-incorporation
Efficiency and Outcomes
Cancer
iMPACT
eNABLeRS
Cost, Quality
Cloud Computing, Wireless
i ud sa, a w-d f a pa a ad w adapy dlv a lal d
f ada m kll a ll wl pag dg aly ga ad mal .
t am mplx ad gly pa pf. tam plag dd y pla g a
ddad mp ad fwa ym alld a tam Plag sym. A fd am pla
d aflly pd ad appvd y adg pya f a d a
pa. t am plag ym a xpv, ad p f plag ff.
i f ak 1 2 wk f a lally apal am pla avd ad appvd y
pya. Mv, am daa d dvdal ad va fma, ly
maa daa ad dffl a daa amg .
i pj, vga wll dvlp a x-ga, w-ad am plag ym
mplyg gap pg (GPu) fwa ad ld mpg. tam plag wll
pfmd ld, ad pal wll mply pay a f f pg a pla. Mv, w ym, GPu-ad mpa g d pd p mpaally v ak
plag p, a a pmal am pla a ampld vy apdly ad g
gfaly l pya m. cmg f f ld mpg ad GPu g-pd pg,
w ym wll d f am plag, pfal m, ag
am daa ag, ad mpv la f adapy dv.
16
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
19/25
Mobile Mandometer for At-Home Weight NormalizationMichael Leon, PhD, University of California, Irvine
STAGe
CATeGoRy
CoNDiTioN
Company Formed
Behavior Modification
Obesity
iMPACT
eNABLeRS
Cost, Access
Sensors, Wireless
t Mad Gp a dvlpd wa appa a ffv am f y, fa a ly
dmad apy a lavly xpv l-ad pgam w pa a ad
mal fd ak pa g fdak a ag av dg ad w
mal. Pa a mal w a Madm(mad ma i a La), w f a
al a d a d pla a d fma a ag av a mall m.
t ag av f a mal-wg p mg am mal al w m,
allwg pa mdl ag av mal pa. s ag allw m la
mal flg a gd aly wg dvdal ma mal.
t mak pgam avalal may m ppl, gp pp d f am
y mvg f l. ty wll pw f P ad Add pag ym dvlp: 1) a ml malm fdak dv a wll lp pa la g ay dg
a mal, 2) a ml dv a ppl a ly w y a gy, ad 3) a ml val
ap, w a avaa aw m a 4,500 q a av a pv
a w pa, pvdg addal paal pp dd f a ffv wg-l
pgam d f l. t ga wll d dvlp a w-ga al f
malm fdak dv a wll m l xpv pd, a galy mpvd paly,
ad a mma wlly w map.
Alag cmmala f c-savg hal tlg 17
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
20/25
18
Nxt Stps fr HTAP Wnnrst awad a w wkg wad mplg
dvlpm ml a a am ald
w gda fm v Lg adv. t mg
ad yp f a w ga wad v Lg adv vay adg
pf ma ad pj ag f
dvlpm. MbA d fllw fm uc sa
Dg' rady sl f Maagm av
agd f pj w pp
mmala ff g mak a
ad pla dvlpm. hwv, d
gal am: dma Poc ad df a
mmala paway.
ov f ya, awad wll d
a df m d ad mak
ppy, a wll a a mpv
ladap. D. c ad Jag f wm a
plly mmd a mmala pawll
al wk w v Lg adv vw
mdl a appa lva f lgy ad
g wgg p f ag a mpay
kg a l. cg a mmala
paway a a mplx ad dffl d.
cqly, v Lg wll wk w D. c ad
Jag d ad q a:
Lkld f g pa p
W v a plafm lgy
a mal mpvm
capal qm
Mak dyam
iv awa pal
Pal ag a ap ad
lgy
5LooKinG AheAD
Photo 3: Disposable Semiconductor Test Strip Prototype
Photo 4: GPU and Cloud-Based Cancer RadiotherapyTreatment Planning System
Credit: Chi on Chui, UCLA Engineering
Credit: Steve Jiang, UC San Diego Moores Cancer Center
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
21/25
19
if a mm f c Jag am wa l
lgy fm pv vy
ad k apal a a mpay, v Lg wll
wk w pj am fy f
appla ag, fm f mak
ppy, ad vala va gap-fdg
pp. Fdg p mg ld applyg
f a small b iva ra (sbir)
a appag aly-ag v g
da w gp a gal agl
vm wk. v Lg al wll pvd
gda w ppa f fmal pa
v.
D. L ad oa, w av alady fmd
mpa ad pj ad d pva
d apal, wll p a dff pa fwad
ad ag f dvlpm ad mmal
advam da.
D. L ad am wll wkg w gda
fm v Lg mpl fwa dvlpm
ad a al pyp f Ml Madm,
w jv f g ady f pd a
d f htAP pgam pd. if am
mak ff pg, v Lg wll al
pvd gda makg agy ad mak
d addal v.
D. oa v, LucAs, wll fllw a dff
pa. Fd fm htAP awad wll d y oa ra Gp a ucLA dvlp
pf appla f LucAs f p-f-a cbc
g ld gp htAP ppal. A
am m, D. oa w mpay, hlm, LLc,
wll pva vm apal f dvlp
LucAs plafm f addal appla f
lgy. v Lg wll wk w D. oa
ad ceo f hlm d mak ad
pa a qd f-
ad makg pla f appla f LucAs f
cbc g.
iv ad aly pg f awad,
a D. oa ad L, gly agg.
t a aly aa pva apal
dma ll a pl f v wllg
ak g-k vm -avg al
lg, v a aly-ag f dvlpm.
W add f gda fm v Lg ad
ga fdg fm htAP p, LucAs ad
Ml Madmav a gd a f vvg
mmala p ad dlvg f
pa a a lw .
earl insghts and CnsdratnsA htAP awad fg aad, wll
lp llma fll mpa f htAP v m.
Alg htAP wg av a ll a
aly ag, a plmay g a a ff
gda f gvm, vy, ad mmal
akld w a gal f alag
mmala f -avg al lg.
Changing Industry Dynamics. Stakeholders should
increase awareness among researchers about the
implications of industry convergence and changing
payment models.
A a vga lg w
pal d ala , mpa
a awa a w vg a
ala, lf , ad lmma
d a aff dvlpm qm
ad glay p. F xampl, all
f htAP awad dly pad f
wl lg v. A a l,
y wll d apa ml y ad daa
am adad add us Fd
ad Dg Adma appval p f a
ypal mdal dv.
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
22/25
Alag cmmala f c-savg hal tlg 20
i qally mpa f dvlp f aly-ag
al lg dad agg paym
ad mdl. A dy f
wad m gad ad aal mdl
f a dlvy, w al lg wll d
ga w a ag f al fma
lg, ldg l al d.
ra wll al d apa
mpa f aval daa gad d f
adal a g a lp al a m
l vw f pa.
Program Specialization.Funders and universities
should consider the value of programs that target
specific areas of need and opportunity.
htAP lla w a m gald lgy
ala pgam mdl a appld
aa f -avg al lg. Aaly
f htAP m gg a a
ppy f pgam w a v ga dg
f pala. by alg m agd
pgam jv, fd ad pgam fala
a mpv dd f dfyg akg
va aa f al d.
Regional Program Models.Universities and funders
of acceleration programs should consider the value
of regional models and how unique requirements will
affect program development.
Ml-vy mdl a ff gfa val
y dg f dvlpg ala
pgam. ty al f ym f pp
f a ad p a xd
yd a ad f ay gl
vy. hwv, gal mdl may al
a d f w pl ad p.
F htAP, v Lg ald pal agm
w papag v add
qm f a ml-vy pgam, ldg
g ga paym a ad
dvlpm ml.
National Referral Network.Stakeholders should
consider creating an actively managed national referral
network that connects new technologies to funding,
investment, and commercial opportunity.
t f htAP w w al mg
mpllg a da. bad pgam,
a htAP, ff f f aag a dv f da a a lag ppla f a.
i m a, wv, al avalal fdg fall
f wa ay pp all wy
m. sm v may al m
mak a pala pgam, y ld pm f
valad aga dff a.
All akld ld f fm a lag-al
fal wk f aly-ag al lg.
A avly maagd aal wk a gag
v, v, ad mmal lad a
pa wld a addal ppy f
pmg a fd fdg ad mmal
paway yd d f a gl pgam.
Commercial Insight. Industry should work more closely
with universities and funders to establish stronger
connectivity between academic research and defined
commercial needs.
o f m mpa akaway fm htAP
fa pg d f g
w mmal lad ad vy a.
W dv laay, m
a a pdg a pf mak
ppy dg qm f
mmal . t l a g paly
f malgm ad ffy a aly-ag
lg amp fd way mak ad
dy k va. cmmal paway
may v l la a f -avg
al lg. W ga d ad
dfd mmal pp, p wll
m ld lp a dvlp
lg, ad v wll av dd
f .
-
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
23/25
21
enDnotes
1. The Scientist, tp t iva 2011,
Jaay 2012. Avalal a: p://-.
m/2012/01/01/p--va-2011/
2. Ka Famly Fda, hal ca c:
A Pm, May 2012. Avalal a:p://www.kff.g/a/7670.fm
3. c f Mda & Mdad sv, off
f Aay, "naal hal expd
Pj 2010-2020." Avalal a:
p://www.m.gv/ra-sa-Daa-
ad-sym/sa-td-ad-rp/
naalhalexpdDaa/Dwlad/pj2010.pdf
4. t cmmwal Fd, Wy n
b? rl fm naal sad
u.s. hal sym Pfma, 2011,o 2011. Avalal a:
p://www.mmwalfd.g/Pla/
Fd-rp/2011/o/Wy-n--b-2011.apx
5. t bkg i, eglg c f
hal ca rfm, bdg v:
ffv p add lg-m al a
pdg gw, spm 2009. Avalal
a: p://www.kg.d/a/
p/2009/09/01-
6. u.s. cgal bdg off, tlgal
cag ad Gw f hal ca spdg,
Jaay 2008. Avalal a:
p://www..gv/pla/41665
7. b M.b., Ja s.h., ad blmal D., hal
ifma tlgy: Layg t ifa
f naal hal rfm, hal Affa, J
2010, 29(6): 12141219.
8. c c., Gma, J., ad hwag, J.,The Innovators Prescription, MGaw-hll, 2008
9. Al, W.K., Dvg iva i Lag
cpa i: callg Fad y Lag
cpa, The MIT Entrepreneurship Review,
Apl 2010. Avalal a: p://m.m.d/
al/dvg-va-lag-pa--
allg-fad-lag-pa
10. cg h., Vaavk W., ad Jl W,
Open Innovation: Researching a New Paradigm,
oxfd uvy P, 2006
11. Pbs. og, Who Made America, Innovators, Herbert
Boyer. Avalal a: p://www.p.g/wg/
ymadama/wmad/y_.ml
12. G, Corporate Chronology. Avalal a:
p://www.g.m/g/a/pa/
y/ml.ml
13. Pwacp LLP ad naal
V capal Aa, Myt
rp, qaly al d daa fm19992011. Avalal a:
p://www.pwmy.m/MtPl//
av.jp?pag=al
http://the-scientist.com/2012/01/01/top-ten-innovations-2011/http://the-scientist.com/2012/01/01/top-ten-innovations-2011/http://www.kff.org/insurance/7670.cfmhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2010.pdfhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2010.pdfhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2010.pdfhttp://www.commonwealthfund.org/Publications/Fund-Reports/2011/Oct/Why-Not-the-Best-2011.aspxhttp://www.commonwealthfund.org/Publications/Fund-Reports/2011/Oct/Why-Not-the-Best-2011.aspxhttp://www.brookings.edu/research/reports/2009/09/01-btchttp://www.brookings.edu/research/reports/2009/09/01-btchttp://www.cbo.gov/publication/41665http://miter.mit.edu/article/driving-innovation-large-corporations-i-challenges-faced-large-corporationshttp://miter.mit.edu/article/driving-innovation-large-corporations-i-challenges-faced-large-corporationshttp://miter.mit.edu/article/driving-innovation-large-corporations-i-challenges-faced-large-corporationshttp://www.pbs.org/wgbh/theymadeamerica/whomade/boyer_hi.htmlhttp://www.pbs.org/wgbh/theymadeamerica/whomade/boyer_hi.htmlhttp://www.gene.com/gene/about/corporate/history/timeline.htmlhttp://www.gene.com/gene/about/corporate/history/timeline.htmlhttps://www.pwcmoneytree.com/MTPublic/ns/nav.jsp?page=historicalhttps://www.pwcmoneytree.com/MTPublic/ns/nav.jsp?page=historicalhttps://www.pwcmoneytree.com/MTPublic/ns/nav.jsp?page=historicalhttps://www.pwcmoneytree.com/MTPublic/ns/nav.jsp?page=historicalhttp://www.gene.com/gene/about/corporate/history/timeline.htmlhttp://www.gene.com/gene/about/corporate/history/timeline.htmlhttp://www.pbs.org/wgbh/theymadeamerica/whomade/boyer_hi.htmlhttp://www.pbs.org/wgbh/theymadeamerica/whomade/boyer_hi.htmlhttp://miter.mit.edu/article/driving-innovation-large-corporations-i-challenges-faced-large-corporationshttp://miter.mit.edu/article/driving-innovation-large-corporations-i-challenges-faced-large-corporationshttp://miter.mit.edu/article/driving-innovation-large-corporations-i-challenges-faced-large-corporationshttp://www.cbo.gov/publication/41665http://www.brookings.edu/research/reports/2009/09/01-btchttp://www.brookings.edu/research/reports/2009/09/01-btchttp://www.commonwealthfund.org/Publications/Fund-Reports/2011/Oct/Why-Not-the-Best-2011.aspxhttp://www.commonwealthfund.org/Publications/Fund-Reports/2011/Oct/Why-Not-the-Best-2011.aspxhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2010.pdfhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2010.pdfhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2010.pdfhttp://www.kff.org/insurance/7670.cfmhttp://the-scientist.com/2012/01/01/top-ten-innovations-2011/http://the-scientist.com/2012/01/01/top-ten-innovations-2011/ -
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
24/25
22
14. b All haml aaly
15. c f V ra, t Agl iv
Mak 2002: ivm Avy ad Gw
Pp, J 2003. Avalal a: p://w.
.d/fl/c_f_V_ra_
P_rla_J_2003_-_t_Agl_iv_
Mak__2002.pdf
16. c f V ra, t Agl iv
Mak 2010: A Mak rd, Apl
2011. Avalal a: p://w..d//
dfal/fl/2010_aaly_p.pdf
17. Aa f uvy tlgy Maag,
ty Ya Af Paag, bay-Dl A Dv
emy, P Pl hal, May 2010.
Avalal a: p://www.ww.m/al/
y-ya-af-paag-ay-dl-a-dv--
my-p-pl-al
18. Ga Mak hal, Gd impa
ivg, May 2011. Avalal a: www.g.g/
fl/d/Gih_Gd__impa_ivg_
FinAL_May_2011.pdf
19. id.
20. cg, h.W, t ea f op iva,
Sloan Management Review, 2003, 44, 3 (spg):
3541
21. ra, M, Pf a aadmaaga, Nature Biotechnology, 2011, 29 (1), 34.
Avalal a: p://www.a.m//jal/
v29/1/fll/0111-3.ml
22. MKy & c, Ad w capg
pm f plap p, Jly
2009. Avalal a: p://www.mky.m/
App_Mda/rp/sso/Ad__w_.pdf
23. id.
24. Mlad, Mk, Ge p a a,
Healthcare IT News, nvm 3, 2011. Avalal
a: p://www.alaw.m/w/
g-p-a-a
25. ud sa cg, h. Mdal
iva P A f 2007. Avalal a:
p://www.gp.gv/fdy/pkg/biLLs-
1102210/pdf/biLLs-1102210.pdf
26. www.allg.gv
27. J, J., Mind the Gap: The Evolution of
Technology Commercialization, the Growing FundingGap, and What Research Institutions Are Doing About
It," off f b Dvlpm, uvy f
Ma, 2005. Avalal q.
28. J, J., Mind the Gap 2011: The University
Gap Funding Report, iv, nvm
2011. Avalal a: p://www.gapfdg.g/
addm/MtG11_ovvw.pdf
29. id.
30. v Lg c aaly f htAP appla.
i m a, l xama f
m dad a mpvm
qaly a may k -m a
.
http://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/sites/default/files/2010_analysis_report.pdfhttp://wsbe.unh.edu/sites/default/files/2010_analysis_report.pdfhttp://www.newswise.com/articles/thirty-years-after-passage-bayh-dole-act-drives-the-economy-protects-public-healthhttp://www.newswise.com/articles/thirty-years-after-passage-bayh-dole-act-drives-the-economy-protects-public-healthhttp://www.newswise.com/articles/thirty-years-after-passage-bayh-dole-act-drives-the-economy-protects-public-healthhttp://www.gih.org/files/usrdoc/GIH_Guide_to_Impact_Investing_FINAL_May_2011.pdfhttp://www.gih.org/files/usrdoc/GIH_Guide_to_Impact_Investing_FINAL_May_2011.pdfhttp://www.gih.org/files/usrdoc/GIH_Guide_to_Impact_Investing_FINAL_May_2011.pdfhttp://www.nature.com/nbt/journal/v29/n1/full/nbt0111-3.htmlhttp://www.nature.com/nbt/journal/v29/n1/full/nbt0111-3.htmlhttp://www.mckinsey.com/App_Media/Reports/SSO/And_the_winner_is.pdfhttp://www.mckinsey.com/App_Media/Reports/SSO/And_the_winner_is.pdfhttp://www.healthcareitnews.com/news/ge-puts-cancer-crosshairshttp://www.healthcareitnews.com/news/ge-puts-cancer-crosshairshttp://www.gpo.gov/fdsys/pkg/BILLS-110s2210is/pdf/BILLS-110s2210is.pdfhttp://www.gpo.gov/fdsys/pkg/BILLS-110s2210is/pdf/BILLS-110s2210is.pdfhttp://www.challenge.gov/http://www.gapfunding.org/shareddocuments/MTG11_Overview.pdfhttp://www.gapfunding.org/shareddocuments/MTG11_Overview.pdfhttp://www.challenge.gov/http://www.gpo.gov/fdsys/pkg/BILLS-110s2210is/pdf/BILLS-110s2210is.pdfhttp://www.gpo.gov/fdsys/pkg/BILLS-110s2210is/pdf/BILLS-110s2210is.pdfhttp://www.healthcareitnews.com/news/ge-puts-cancer-crosshairshttp://www.healthcareitnews.com/news/ge-puts-cancer-crosshairshttp://www.mckinsey.com/App_Media/Reports/SSO/And_the_winner_is.pdfhttp://www.mckinsey.com/App_Media/Reports/SSO/And_the_winner_is.pdfhttp://www.nature.com/nbt/journal/v29/n1/full/nbt0111-3.htmlhttp://www.nature.com/nbt/journal/v29/n1/full/nbt0111-3.htmlhttp://www.gih.org/files/usrdoc/GIH_Guide_to_Impact_Investing_FINAL_May_2011.pdfhttp://www.gih.org/files/usrdoc/GIH_Guide_to_Impact_Investing_FINAL_May_2011.pdfhttp://www.gih.org/files/usrdoc/GIH_Guide_to_Impact_Investing_FINAL_May_2011.pdfhttp://www.newswise.com/articles/thirty-years-after-passage-bayh-dole-act-drives-the-economy-protects-public-healthhttp://www.newswise.com/articles/thirty-years-after-passage-bayh-dole-act-drives-the-economy-protects-public-healthhttp://www.newswise.com/articles/thirty-years-after-passage-bayh-dole-act-drives-the-economy-protects-public-healthhttp://wsbe.unh.edu/sites/default/files/2010_analysis_report.pdfhttp://wsbe.unh.edu/sites/default/files/2010_analysis_report.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdfhttp://wsbe.unh.edu/files/Center_for_Venture_Research_Press_Release_June_2003_-_The_Angel_Investor_Market_in_2002.pdf -
7/31/2019 Accelerating Commercialization Cost Saving Health Technologies Report
25/25